771572-39-5

Basic information

• Product Name: (2-Methyl-4-(trifluoroMethoxy)phenyl)MethanaMine
• Synonyms: (2-Methyl-4-(trifluoroMethoxy)phenyl)MethanaMine;[2-Methyl-4-(trifluoromethoxy)phenyl]methylamine, 2-(Aminomethyl)-5-(trifluoromethoxy)toluene;2-Methyl-4-(trifluoromethoxy)benzylamine
• CAS NO: 771572-39-5
• Molecular Formula: C₉H₁₀F₃NO
• Molecular Weight: 205.1770096
• Mol File: 771572-39-5.mol

Chemical Properties

• Boiling Point: 219.6±35.0 °C(Predicted)
• Appearance: /
• Density: 1.235±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 8.93±0.10(Predicted)
• CAS DataBase Reference: (2-Methyl-4-(trifluoroMethoxy)phenyl)MethanaMine(CAS DataBase Reference)
• NIST Chemistry Reference: (2-Methyl-4-(trifluoroMethoxy)phenyl)MethanaMine(771572-39-5)
• EPA Substance Registry System: (2-Methyl-4-(trifluoroMethoxy)phenyl)MethanaMine(771572-39-5)

Safety Data

• Hazardous Substances Data: 771572-39-5(Hazardous Substances Data)

Usage

General Description

(2-Methyl-4-(trifluoroMethoxy)phenyl)MethanaMine, also known as 4-(Trifluoromethoxy)phenylmethylamine, is a chemical compound with the molecular formula C9H10F3NO. It is a derivative of phenylmethylamine, with a trifluoromethoxy group attached to the fourth carbon atom. (2-Methyl-4-(trifluoroMethoxy)phenyl)MethanaMine is commonly used in the pharmaceutical and research industries as a building block for the synthesis of various drugs and compounds. It has also shown potential as an agent for the treatment of certain medical conditions, although further research is required to fully understand its properties and potential applications. Overall, (2-Methyl-4-(trifluoroMethoxy)phenyl)MethanaMine is an important chemical compound with diverse uses and potential therapeutic benefits.

Upstream product

• 261951-90-0 2-methyl-4-(trifluoromethoxy)benzamide 
• 261951-91-1 2-methyl-4-(trifluoromethoxy)benzoic acid 

Downstream Products

• 1229625-05-1 2-methyl-4-(trifluoromethoxy)benzylamine hydrochloride 
• 945892-12-6 Ethyl 1-[6-fluoro-1-(2-fluoroethyl)-8-methoxy-3-({[2-methyl-4-(trifluoromethoxy)benzyl]amino}carbonyl)-4-oxo-1,4-dihydroquinolin-7-yl]piperidine-4-carboxylate 
• 945892-10-4 Ethyl 1-[6-fluoro-8-methoxy-3-({[2-methyl-4-(trifluoromethoxy)benzyl]amino}carbonyl)-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydroquinolin-7-yl]piperidine-4-carboxylate 
• 945892-28-4 7-[(3S)-3-(2-Ethoxy-2-oxoethyl)piperidin-1-yl]-6-fluoro-8-methoxy-N-[2-methyl-4-(trifluoromethoxy)benzyl]-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydroquinoline-3-carboxamide 
• 945892-29-5 7-[(3R)-3-(2-Ethoxy-2-oxoethyl)piperidin-1-yl]-6-fluoro-8-methoxy-N-[2-methyl-4-(trifluoromethoxy)benzyl]-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydroquinoline-3-carboxamide 
• 945892-13-7 ethyl 1-[6-fluoro-8-methoxy-3-({[2-methyl-4-(trifluoromethoxy)benzyl]amino}carbonyl)-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydroquinolin-7-yl]piperidin-4-ylacetate 
• 945892-39-7 1-[6-Fluoro-8-methoxy-3-({[2-methyl-4-(trifluoromethoxy)benzyl]amino}carbonyl)-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydroquinolin-7-yl]piperidine-4-carboxamide 
• 945892-42-2 1-Cyclopropyl-6-fluoro-8-methoxy-N-[2-methyl-4-(trifluoromethoxy)benzyl]-4-oxo-7-(3-oxo-2,8-diazaspiro[4.5]dec-8-yl)-1,4-dihydroquinoline-3-carboxamide 
• 945892-41-1 6-Fluoro-8-methoxy-N-[2-methyl-4-(trifluoromethoxy)benzyl]-4-oxo-7-(3-oxo-2,8-diazaspiro[4.5]dec-8-yl)-1-(2,2,2-trifluoroethyl)-1,4-dihydroquinoline-3-carboxamide 
• 945892-40-0 6-fluoro-7-[(all-cis)-4-hydroxy-3,5-dimethylpiperidin-1-yl]-8-methoxy-N-[2-methyl-4-(trifluoromethoxy)benzyl]-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydroquinoline-3-carboxamide 

Relevant articles and documents

SUBSTITUTED QUINOLONES III

The invention relates to substituted quinolones and to methods for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.

Substituted quinolones II

The invention relates to substituted quinolones of formula (I) and to methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particu

SUBSTITUTED QUINOLONES

The invention relates to substituted quinolones methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular, for use as antiviral agents, in particular, against cytomegaloviruses.